JY
SGNT

Jeff Yass’s SAGENT PHARMACEUTICALS INC COM STK (DE) SGNT Stock Holding History

Jeff Yass’s Portfolio SGNT Stock Details SGNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-19,635
Closed -$301K – 10420
2015
Q3 		$301K Buy
19,635
+9,822
+100% +$212K ﹤0.01% 8034
2015
Q2 		$239K Buy
+9,813
New +$235K ﹤0.01% 8974
2015
Q1 		– Sell
-21,400
Closed -$537K – 10387
2014
Q4 		$537K Buy
+21,400
New +$628K ﹤0.01% 7082

Other funds holding SGNT

Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
EAM
EverPoint Asset Management Stamford, Connecticut $5.38B AUM 21.45% 1-Year Est. Return
PCM
Penn Capital Management Philadelphia, Pennsylvania $1.58B AUM 81.2% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $143M AUM 102.52% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Jeff Yass's SGNT Position: Q4 2015 in Review

Jeff Yass sold out of SAGENT PHARMACEUTICALS INC COM STK (DE) (SGNT) in Q4 2015, closing a stake of 19,635 shares — an estimated $301K sold.

Jeff Yass first reported a position in SGNT in Q4 2014 and held it in 3 quarters. The position peaked at $537K in Q4 2014. 134 funds tracked by Wall St. Rank hold SGNT as of Q4 2015.

  • Jeff Yass reported no remaining SAGENT PHARMACEUTICALS INC COM STK (DE) position as of Q4 2015 after selling out during the quarter.
  • Jeff Yass sold 19,635 SAGENT PHARMACEUTICALS INC COM STK (DE) shares in Q4 2015, an estimated $301K.
  • Jeff Yass first reported a position in SAGENT PHARMACEUTICALS INC COM STK (DE) in Q4 2014 and held it in 3 quarters.
  • Jeff Yass's SAGENT PHARMACEUTICALS INC COM STK (DE) position peaked at $537K in Q4 2014.
  • 134 funds tracked by Wall St. Rank held SAGENT PHARMACEUTICALS INC COM STK (DE) as of Q4 2015.

Based on Susquehanna International Group's 13F filing for Q4 2015, filed 16 Feb 2016.